About the 2023 Country 2 Country 4 Cancer Ride
For the 8th year, the 2023 edition of the Country 2 Country 4 Cancer (C2C4C) ride will feature more than 90 Bristol Myers Squibb employees riding in Germany, Switzerland, France, Spain and the United Kingdom for nearly 2,200 kilometers from 1-18 September. The total length of the ride is 18 days and will be split into three days per each team. This year is a celebration of 10 years of C2C4C with the inaugural ride taking place in the United States in 2014.
Since 2016, nearly 550 Bristol Myers Squibb employees in Europe have raised more $2.6 million USD through the Country 2 Country 4 Cancer Ride.
In this 2023 edition, six teams will feature riders participating from 19 countries including Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, the United States and for the first time, participants from the Czech Republic, Hungary, Poland and Romania. The goal of C2C4C is to raise awareness for cancer research and European cancer organisations who are members of the UICC.
Raising Funds for the Spanish Association Against Cancer (Asociación Española Contra el Cáncer)
AECC is a non-profit organization formed by cancer patients, family members, volunteers, collaborators and professionals providing support and assistance services throughout Spain. It mission is to alleviate and prevent, as far as possible, the suffering caused by cancer in people, regardless of their place of residence and personal circumstances.
Who Are the Riders
The participants are novice riders, who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. Their kilometres will help raise funds to fight against cancer by supporting Asociatia Daruieste Viata, a member of the Union for International Cancer Control.
About BMS
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases
About the UICC
The Union for International Cancer Control (UICC)is the largest global membership organization dedicated to the fight against cancer. Founded in Geneva in 1933, UICC has some 1,200 member organisations in 172 countries. UICC’s mission is to both unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity and ensure that cancer control remains a priority on the global health and development agenda.
